Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 22, 2019DrugsOpen Access

Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment Modalities

View Full Paper
Ask AI
Bookmark
Share

Authors

PMPaul MankaUniversitätsklinikum Knappschaftskrankenhaus BochumAZAmos ZellerEssen University HospitalWSWing‐Kin SynMedical University of South Carolina

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Manka et al. (2019) studied this question.

synapsesocial.com/papers/6a0f6f678090e499da5fc89ahttps://doi.org/10.1007/s40265-019-01126-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy2015 · 521 citations
  2. 2Effect of Losartan, An Angiotensin Ii Receptor Antagonist, on Portal Pressure in Cirrhosis1999 · 202 citations
  3. 3Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C2012 · 32 citations
  4. 4Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease2018 · 194 citations
  5. 5Beneficial Effect of Angiotensin-Blocking Agents on Graft Fibrosis in Hepatitis C Recurrence after Liver Transplantation2004 · 92 citations